Studion Promotes Brian Harrington to General Manager of Life Sciences Business to Drive Growth of eClinical Services Studion, a technology services company specializing in the design, development, and delivery of…
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd, and Polpharma…
Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate Bausch + Lomb Corporation a leading global eye health company dedicated to helping people see better to live better,…
Evolus Expands Aesthetic Portfolio with Exclusive U.S. Licensing Agreement for Profhilo®, Europe’s Leading Injectable Skin Quality Treatment Evolus, Inc., a global performance beauty company focused on developing innovative consumer aesthetic…
Bifrost Biosystems Signs Commercial Supply Agreement with Illumina to Accelerate Optical Pooled Screening Platform Launch Bifrost Biosystems has announced a significant commercial milestone with the signing of a supply agreement…
Retham Technologies Launches Next-Generation Cryoplatelets to Improve Platelet Research and Laboratory Testing Retham Technologies, Inc. has announced the commercial launch of Retham Cryoplatelets™, a next-generation functional platelet product developed to…
Randomized Trial Highlights Ketogenic Diet Benefits in Psychotic Disorders A new clinical study published in Schizophrenia Bulletin has provided encouraging evidence that a ketogenic diet may offer meaningful benefits for…
MEDIPOST Treats First U.S. Patient in Phase III Trial of Investigational Stem Cell Therapy for Knee Osteoarthritis MEDIPOST Inc., a biotechnology company specializing in the development of allogeneic, umbilical cord…
GE HealthCare and Mayo Clinic Launch MI-BET Study to Advance Personalized Radioligand Therapy for Advanced Prostate Cancer GE HealthCare and Mayo Clinic have announced the launch of the Molecular Imaging…
Niagen Bioscience Launches NB4168 Pharmaceutical Program Targeting Rare Genetic Diseases and Accelerated Aging Niagen Bioscience expands its leadership in NAD+ science into pharmaceutical development with NB4168, an investigational oral therapy…
Octave MSDA Test Proven Effective in Identifying True MS Relapse Octave Bioscience, a commercial-stage precision neurology company focused on advancing personalized care for multiple sclerosis (MS) and other neurodegenerative disorders,…
Leo Cancer Care Secures $65 Million Series D Funding to Expand Upright Cancer Imaging and Treatment Platform Leo Cancer Care has announced the successful completion of an oversubscribed $65 million…